Waltermire Robert E. 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jan 17, 2025
Insider Transaction Report
Form 4
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
Transactions
- Sale
Common Stock
2025-01-17$273.41/sh−442$120,847→ 5,058 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.